These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29294018)

  • 1. Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.
    de Vries RD; Nieuwkoop NJ; van der Klis FRM; Koopmans MPG; Krammer F; Rimmelzwaan GF
    J Infect Dis; 2017 Dec; 217(1):3-11. PubMed ID: 29294018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.
    de Vries RD; Nieuwkoop NJ; Krammer F; Hu B; Rimmelzwaan GF
    Virus Res; 2020 Feb; 277():197839. PubMed ID: 31837382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
    de Vries RD; Nieuwkoop NJ; Pronk M; de Bruin E; Leroux-Roels G; Huijskens EGW; van Binnendijk RS; Krammer F; Koopmans MPG; Rimmelzwaan GF
    Vaccine; 2017 Jan; 35(2):238-247. PubMed ID: 27914742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADCC: An underappreciated correlate of cross-protection against influenza?
    de Vries RD; Hoschler K; Rimmelzwaan GF
    Front Immunol; 2023; 14():1130725. PubMed ID: 36911705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-lineage protection by human antibodies binding the influenza B hemagglutinin.
    Liu Y; Tan HX; Koutsakos M; Jegaskanda S; Esterbauer R; Tilmanis D; Aban M; Kedzierska K; Hurt AC; Kent SJ; Wheatley AK
    Nat Commun; 2019 Jan; 10(1):324. PubMed ID: 30659197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.
    Laporte M; Stevaert A; Raeymaekers V; Boogaerts T; Nehlmeier I; Chiu W; Benkheil M; Vanaudenaerde B; Pöhlmann S; Naesens L
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay.
    Chromikova V; Tan J; Aslam S; Rajabhathor A; Bermudez-Gonzalez M; Ayllon J; Simon V; García-Sastre A; Salaun B; Nachbagauer R; Krammer F
    Vaccine; 2020 Feb; 38(8):1953-1961. PubMed ID: 31959425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
    Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
    J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model.
    Carreño JM; Strohmeier S; Kirkpatrick Roubidoux E; Hai R; Palese P; Krammer F
    mBio; 2020 Dec; 11(6):. PubMed ID: 33323511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
    Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
    Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.
    Jegaskanda S; Amarasena TH; Laurie KL; Tan HX; Butler J; Parsons MS; Alcantara S; Petravic J; Davenport MP; Hurt AC; Reading PC; Kent SJ
    J Virol; 2013 Dec; 87(24):13706-18. PubMed ID: 24109221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
    Jegaskanda S; Vandenberg K; Laurie KL; Loh L; Kramski M; Winnall WR; Kedzierska K; Rockman S; Kent SJ
    J Infect Dis; 2014 Dec; 210(11):1811-22. PubMed ID: 24916185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
    Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection.
    Wong SS; Waite B; Ralston J; Wood T; Reynolds GE; Seeds R; Newbern EC; Thompson MG; Huang QS; Webby RJ;
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans.
    Christensen SR; Toulmin SA; Griesman T; Lamerato LE; Petrie JG; Martin ET; Monto AS; Hensley SE
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.
    Jegaskanda S; Co MDT; Cruz J; Subbarao K; Ennis FA; Terajima M
    J Infect Dis; 2017 Mar; 215(5):818-823. PubMed ID: 28011910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.